Skip to main content
. 2012 Apr 30;119(24):5650–5658. doi: 10.1182/blood-2012-03-378992

Table 2.

Activity of radiation or alkylator-based therapies for the treatment of POEMS syndrome

Regimen Outcome
Radiation9,4346 ≥ 50% of patients have significant clinical improvement
Mel-Dex38 81% hematologic response rate; 100% with some neurologic improvement
Corticosteroids5 ≥ 15% of patients have significant clinical improvement
ASCT5 100% of surviving patients have significant clinical improvement